This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Pfizer Inc.

Drug Names(s): azithromycin extended release oral suspension, azithromycin SR

Description: Zmax is an extended release formulation of Zithromax. Zmax is given as a single, one-time 2 gram dose.

The active ingredient, azithromycin, is an azalide, a subclass of macrolide antibiotics. It exerts its antimicrobial effects by binding to bacterial 50S ribosomal subunit, thus blocking bacterial protein synthesis.

Zmax News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug